Searchable abstracts of presentations at key conferences in endocrinology

ea0081s18.1 | Unmet needs in aggressive endocrine cancers | ECE2022

Choosing the best treatment sequence for gepnet tumours

Janson Eva Tiensuu

Background: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are grouped according to the origin of the primary tumor and their proliferation index (Ki-67). The WHO classification divide GEP-NETs into G1 (Ki-67 <3%), G2 (Ki-67 ≥3-20%) and G3 (Ki-67 >20%). Both parameters are accounted for when treatment strategies are planned. Furthermore, the presence of hormone related symptoms warrant consideration.Aim: To describe the treatment l...